Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands

S Rosenbloom; S Yount; K Yost; D Hampton; D Paul; A Abernethy; P Jacobsen; K Syrjala; J Von Roenn; David Cella

Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands

S Rosenbloom, S Yount, K Yost, D Hampton, D Paul, A Abernethy, P Jacobsen, K Syrjala, J Von Roenn, David Cella

Medical Social Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English
Title of host publication	The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research
Editors	I Farquhar, K Summers, A Sorkin
Publisher	Emerald Group Publishing Inc.
Pages	53-66
State	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Rosenbloom, S., Yount, S., Yost, K., Hampton, D., Paul, D., Abernethy, A., Jacobsen, P., Syrjala, K., Von Roenn, J., & Cella, D. (2008). Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands. In I. Farquhar, K. Summers, & A. Sorkin (Eds.), The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research (pp. 53-66). Emerald Group Publishing Inc..

Rosenbloom, S ; Yount, S ; Yost, K et al. / Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands. The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research. editor / I Farquhar ; K Summers ; A Sorkin. Emerald Group Publishing Inc., 2008. pp. 53-66

@inbook{9c237beca19c41a5b0a49358f9ed261f,

title = "Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands",

author = "S Rosenbloom and S Yount and K Yost and D Hampton and D Paul and A Abernethy and P Jacobsen and K Syrjala and {Von Roenn}, J and David Cella",

year = "2008",

language = "English",

pages = "53--66",

editor = "I Farquhar and K Summers and A Sorkin",

booktitle = "The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research",

publisher = "Emerald Group Publishing Inc.",

}

Rosenbloom, S, Yount, S, Yost, K, Hampton, D, Paul, D, Abernethy, A, Jacobsen, P, Syrjala, K, Von Roenn, J & Cella, D 2008, Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands. in I Farquhar, K Summers & A Sorkin (eds), The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research. Emerald Group Publishing Inc., pp. 53-66.

Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands. / Rosenbloom, S; Yount, S; Yost, K et al.
The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research. ed. / I Farquhar; K Summers; A Sorkin. Emerald Group Publishing Inc., 2008. p. 53-66.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

TY - CHAP

T1 - Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands

AU - Rosenbloom, S

AU - Yount, S

AU - Yost, K

AU - Hampton, D

AU - Paul, D

AU - Abernethy, A

AU - Jacobsen, P

AU - Syrjala, K

AU - Von Roenn, J

AU - Cella, David

PY - 2008

Y1 - 2008

M3 - Chapter

SP - 53

EP - 66

BT - The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research

A2 - Farquhar, I

A2 - Summers, K

A2 - Sorkin, A

PB - Emerald Group Publishing Inc.

ER -

Rosenbloom S, Yount S, Yost K, Hampton D, Paul D, Abernethy A et al. Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands. In Farquhar I, Summers K, Sorkin A, editors, The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research. Emerald Group Publishing Inc. 2008. p. 53-66